This study highlights the overexpression of WT1 in advanced KS cases and a mechanism of KSHV vFLIP- mediated WT1 upregulation and underscores the potential for immunotherapy directed against WT1 as a novel strategy to treat Kaposi sarcoma. The gene discussed is WT1; the disease is Kaposi's sarcoma.